Elevated histone acetylations in Müller cell contribute to inflammation: A novel inhibitory effect of minocycline

GLIA

Volumn 60, Issue 12, 2012, Pages 1896-1905

  Wang, Lei Lei ^a   Chen, Hong ^b   Huang, Kun ^b,c   Zheng, Ling ^a  

^a WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Wuhan Institute of Biotechnology   (China)

Author keywords

Diabetic retinopathy; Histone acetylation; Inflammation; Minocycline; M ller cell

Indexed keywords

BUTYRIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE H3; MINOCYCLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DOWN REGULATION; GENE OVEREXPRESSION; HISTONE ACETYLATION; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; INFLAMMATION; MALE; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA; UPREGULATION;

ACETYLATION; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; HISTONES; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MINOCYCLINE; RATS; RATS, SPRAGUE-DAWLEY; RETINA;

EID: 84867631306     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22405     Document Type: Article

References (51)

1. Barber AJ, Antonetti DA, Gardner TW. 2000. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci 41: 3561-3568.
2. Bhatt LK, Addepalli V. 2010. Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats. Am J Transl Res 2: 181-189.
3. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME, El-Osta A. 2009. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58: 1229-1236.
4. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne NN, Reichenbach A. 2006. Muller cells in the healthy and diseased retina. Prog Retin Eye Res 25: 397-424.
5. Bugger H, Chen D, Riehle C, Soto J, Theobald HA, Hu XX, Ganesan B, Weimer BC, Abel ED. 2009. Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice. Diabetes 58: 1986-1997.
6. Cheung N, Mitchell P, Wong TY. 2010. Diabetic retinopathy. Lancet 376: 124-136.
7. Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M. 2004. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes 53: 2404-2411.
8. Du Y, Smith MA, Miller CM, Kern TS. 2002. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80: 771-779.
9. Dyer MA, Cepko CL. 2000. Control of Muller glial cell proliferation and activation following retinal injury. Nat Neurosci 3: 873-880.
10. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M. 2008. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205: 2409-2417.
11. Fisher SK, Lewis GP. 2003. Muller cell and neuronal remodeling in retinal detachment and reattachment and their potential consequences for visual recovery: A review and reconsideration of recent data. Vision Res 43: 887-897.
12. Fletcher EL, Downie LE, Ly A, Ward MM, Batcha AH, Puthussery T, Yee P, Hatzopoulos KM. 2008. A review of the role of glial cells in understanding retinal disease. Clin Exp Optom 91: 67-77.
13. Gaikwad AB, Sayyed SG, Lichtnekert J, Tikoo K, Anders HJ. 2010. Renal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes. Am J Pathol 176: 1079-1083.
14. Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P. 2005. Expression of acute-phase response proteins in retinal Muller cells in diabetes. Invest Ophthalmol Vis Sci 46: 349-357.
15. Ghosh S, Hayden MS. 2008. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 8: 837-848.
16. Harada C, Okumura A, Namekata K, Nakamura K, Mitamura Y, Ohguro H, Harada T. 2006. Role of monocyte chemotactic protein-1 and nuclear factor kappa B in the pathogenesis of proliferative diabetic retinopathy. Diabetes Res Clin Pract 74: 249-256.
17. Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S, Adamis AP. 2002. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 16: 438-440.
18. Kadiyala CS, Zheng L, Du Y, Yohannes E, Kao HY, Miyagi M, Kern TS. 2012. Acetylation of retinal histones in diabetes increases inflammatory proteins; effects of minocycline and manipulation of histone acetyl transferase (HAT) and histone deacetylase (HDAC). J Biol Chem 287: 25869-25880.
19. Katto J, Mahlknecht U. 2011. Epigenetic regulation of cellular adhesion in cancer. Carcinogenesis 32: 1414-1418.
20. Kern TS. 2007. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007: 95-103.
21. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, Levison SW. 2005. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54: 1559-1565.
22. Lewis GP, Chapin EA, Luna G, Linberg KA, Fisher SK. 2010. The fate of Muller's glia following experimental retinal detachment: Nuclear migration, cell division, and subretinal glial scar formation. Mol Vis 16: 1361-1372.
23. Lewis GP, Fisher SK. 2000. Muller cell outgrowth after retinal detachment: Association with cone photoreceptors. Invest Ophthalmol Vis Sci 41: 1542-1545.
24. Lin M, Chen Y, Jin J, Hu Y, Zhou KK, Zhu M, Le YZ, Ge J, Johnson RS, Ma JX. 2011. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Muller cells. Diabetologia 54: 1554-1566.
25. Lundkvist A, Reichenbach A, Betsholtz C, Carmeliet P, Wolburg H, Pekny M. 2004. Under stress, the absence of intermediate filaments from Muller cells in the retina has structural and functional consequences. J Cell Sci 117: 3481-3488.
26. Miao F, Gonzalo IG, Lanting L, Natarajan R. 2004. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 279: 18091-18097.
27. Mizutani M, Gerhardinger C, Lorenzi M. 1998. Muller cell changes in human diabetic retinopathy. Diabetes 47: 445-449.
28. Mizutani M, Kern TS, Lorenzi M. 1996. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97: 2883-2890.
29. Ning J, Zheng G, Yang YC. 2008. Tip60 modulates PLAGL2-mediated transactivation by acetylation. J Cell Biochem 103: 730-739.
30. Perrone L, Devi TS, Hosoya K, Terasaki T, Singh LP. 2009. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol 221: 262-272.
31. Peterson CL, Laniel MA. 2004. Histones and histone modifications. Curr Biol 14: R546-R551.
32. Pfitzner E, Kliem S, Baus D, Litterst CM. 2004. The role of STATs in inflammation and inflammatory diseases. Curr Pharm Des 10: 2839-2850.
33. Roesch K, Jadhav AP, Trimarchi JM, Stadler MB, Roska B, Sun BB, Cepko CL. 2008. The transcriptome of retinal Muller glial cells. J Comp Neurol 509: 225-238.
34. Rungger-Brandle E, Dosso AA, Leuenberger PM. 2000. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41: 1971-1980.
35. Sarthy VP, Brodjian SJ, Dutt K, Kennedy BN, French RP, Crabb JW. 1998. Establishment and characterization of a retinal Muller cell line. Invest Ophthalmol Vis Sci 39: 212-216.
36. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
37. Sealy L, Chalkley R. 1978. The effect of sodium butyrate on histone modification. Cell 14: 115-121.
38. Tikoo K, Meena RL, Kabra DG, Gaikwad AB. 2008. Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy. Br J Pharmacol 153: 1225-1231.
39. Tout S, Chan-Ling T, Hollander H, Stone J. 1993. The role of Muller cells in the formation of the blood-retinal barrier. Neuroscience 55: 291-301.
40. Umapathy NS, Li W, Mysona BA, Smith SB, Ganapathy V. 2005. Expression and function of glutamine transporters SN1 (SNAT3) and SN2 (SNAT5) in retinal Muller cells. Invest Ophthalmol Vis Sci 46: 3980-3987.
41. Verdone L, Agricola E, Caserta M, Di Mauro E. 2006. Histone acetylation in gene regulation. Brief Funct Genomic Proteomic 5: 209-221.
42. Verrier L, Vandromme M, Trouche D. 2011. Histone demethylases in chromatin cross-talks. Biol Cell 103: 381-401.
43. Vincent JA, Mohr S. 2007. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes 56: 224-230.
44. Wang J, Xu X, Elliott MH, Zhu M, Le YZ. 2010. Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 59: 2297-2305.
45. Wang L, Li C, Guo H, Kern TS, Huang K, Zheng L. 2011. Curcumin inhibits neuronal and vascular degeneration in retina after ischemia and reperfusion injury. PLoS One 6: e23194.
46. Yun JM, Jialal I, Devaraj S. 2010. Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem 22: 450-458.
47. Zhang Y, Xu G, Ling Q, Da C. 2011. Expression of aquaporin 4 and Kir4.1 in diabetic rat retina: Treatment with minocycline. J Int Med Res 39: 464-479.
48. Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS. 2007. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 56: 337-345.
49. Zheng L, Szabo C, Kern TS. 2004. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 53: 2960-2967.
50. Zhong Q, Kowluru RA. 2010. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. J Cell Biochem 110: 1306-1313.
51. Zhong Q, Kowluru RA. 2011. Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy. Diabetes 60: 1304-1313.